Task-sharing mental health care with non-specialist providers benefits adults with psychologic distress after experiencing violence.
The Food and Drug Administration (FDA) has granted Fast Track designation to remlifanserin for the treatment of hallucinations and delusions associated with Alzheimer disease psychosis (ADP).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results